Navigation Links
Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy
Date:8/19/2010

  • Global sites
  • PR Newswire: news distribution, targeting and monitoring
    1. Products & Services
    2. Knowledge Center
    3. Browse News Releases
    4. Contact PR Newswire
    Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services,
    SOURCE Sirtex
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
    2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)...  Encision Inc. (OTCQB:ECIA), a medical device company owning ... in minimally invasive surgery, today announced financial results for ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $311 thousand, or $(0.04) per share, in the ...
    (Date:7/29/2014)... , July 29, 2014   ... announced that it has taken an exclusive worldwide licence ... Ltd, a Durham University spin-out ... will pay an upfront fee, development and commercial milestone ... has also taken an option for additional exclusive licences ...
    (Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
    Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
    (Date:7/29/2014)... 2014 This month, Therapy Changes ... to a Successful, Balanced Career.” The guide is geared ... seeking guidance on creating a successful career. , ... focus, determination, and understanding your strengths and limits,” says ... guide will uncover the elements to creating balance in ...
    (Date:7/29/2014)... 29, 2014 Premier Women’s Health ... Moon Township areas, has affiliated with Allegheny Health Network’s ... continue to deliver babies and perform surgical procedures at ... care will be referred to Allegheny Health Network’s ... be associated with West Penn Hospital and its highly ...
    (Date:7/29/2014)... Regents Health Resources, a consulting firm ... health care industry veteran Daryl Demonbreun and former St. ... the company’s ambitious plans to grow into a full-service ... moving along at a steady pace for nearly 20 ... notch,” says Bob Maier, founder and chief executive officer ...
    (Date:7/29/2014)... 2014 This Latest Guidebook for Conducting ... (2014 Edition) not only provided a comprehensive and thorough ... for imported drug registration but also introduced the practical ... guide you to use the Chinese trial venues to ... world step by step. , The audiences of this ...
    (Date:7/29/2014)... (CA) method is in principle suitable to find out ... widely use it in health economic evaluations, some (primarily ... the result of a pilot project by the German ... Following the Analytic Hierarchy Process (AHP), CA is the ... experts. , Summarize outcome-specific results to an overall ...
    Breaking Medicine News(10 mins):Health News:Therapy Changes Releases New Guide to Building a Successful Career 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 3Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:Determine patient preferences by means of conjoint analysis 2Health News:Determine patient preferences by means of conjoint analysis 3Health News:Determine patient preferences by means of conjoint analysis 4
    ... may be an effective treatment for patients with a ... which was focused on the mechanism by which an ... important role because it suggests that changes in light ... inhibits mating of the C. neoformans -- a potentially ...
    ... risk of vertebral bone fractures in women with low bone ... 55 and 80 years with bone mineral density T scores ... women randomly received five milligrams of alendronate for two years ... placebo. ,The risk of vertebral fracture was significantly reduced ...
    ... and people without liver cancer found that diabetics are stand ... to the general population. ,After taking other factors into ... disease, researchers found diabetes nearly tripled the risk of liver ... factor for liver cancer, may be boosting the risk even ...
    ... be a treatment for life-threatening asthma (LTA) in children, according ... were treated with intravenous administration of sodium bicarbonate to reduce ... in LTA. , It was seen that in 17 ... was a decrease in blood carbon dioxide levels accompanied by ...
    ... the standard test to detect dementia so that it ... early. The test called National Institute //of Ageing's ... list (CWL) needs only ten minutes to administer. ... dementia as these stages often go undetected. They used ...
    ... as folate or a form of vitamin B. this vitamin if ... having a twin baby or to avoid //neural tube defect. A ... proof for this common belief. ,The study was conducted ... there are some countries were it is a common practice to ...
    Cached Medicine News:
    ... Aplicare's saturated swabsticks are packaged in ... 4 inch swabstick is saturated with precisely ... The Gel Swabstick is saturated with a ... The gel is also approved for venipuncture ...
    ... BETADINE® Spray provides 5% ... pump spray. It delivers ... wounds too tender to ... and is indicated whenever ...
    ... that does not contain Alcohol. ... destroys over 99% of bacteria. ... of minor wounds, burns, cuts, ... personal utensils and tools. Prevents ...
    BETADINE® Surgical Scrub is a microbicidal, sudsing cleanser that promptly kills most bacteria, fungi, viruses, protozoa and yeasts. It is indicated for hand hygiene, surgical hand-scrubbing, an...
    Medicine Products: